|
GB201811169D0
|
|
New compounds
|
|
GB201807898D0
|
|
New processes and products with increased chiral purity
|
|
CN109563092A
|
|
It can be used as the 2- phenylimidazole of the active inhibitor of mammal tyrosine kinase ROR1 simultaneously [4,5-B] pyridine -7- amine derivative
|
|
AU2016375634A1
|
|
Bicyclic hydroxamic acids useful as inhibitors of mammalian histone deacetylase activity
|
|
US2016221938A1
|
|
Bisarylsulfonamides useful in the treatment of inflammation and cancer
|
|
WO2016124553A1
|
|
2-phenyl-3h-imidazo[4,5-b]pyridine derivates useful as inhibitors of mammalian tyrosine kinase ror1 activity
|
|
AU2015394628A1
|
|
Benzimidazole derivates useful as inhibitors of mammalian histone deacetylase activity
|
|
NZ626950A
|
|
Bisarylsulfonamides useful in the treatment of inflammation and cancer
|
|
EP2649098A1
|
|
Antibodies against ror1 and their uses
|
|
WO2012035171A2
|
|
Sulfonamide compounds
|
|
WO2011161201A1
|
|
Bisarylsulfonamides useful as kinase inhibitors in the treatment of inflammation and cancer
|
|
EP2513146A2
|
|
Antibodies against ror1 capable of inducing cell death of cll
|
